The activation of PD-1/PD-L1 signaling is not only associated with maintaining autoimmune homeostasis and establishing peripheral immune tolerance, but also involved in tumor progression and immune evasion, serving as a crucial inhibitor of both innate immune and adaptive immune systems [152]. This evidence concerns the gene PDCD1 and neoplasm.